PHATHOM PHARMACEUTICALS, INC. (PHAT): Price and Financial Metrics
PHAT Price/Volume Stats
| Current price | $8.73 | 52-week high | $19.71 |
| Prev. close | $9.37 | 52-week low | $6.07 |
| Day low | $8.55 | Volume | 1,353,600 |
| Day high | $9.59 | Avg. volume | 912,258 |
| 50-day MA | $16.03 | Dividend yield | N/A |
| 200-day MA | $12.17 | Market Cap | 596.93M |
PHAT Stock Price Chart Interactive Chart >
PHATHOM PHARMACEUTICALS, INC. (PHAT) Company Bio
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Buffalo Grove, IL.
PHAT Price Returns
| 1-mo | -47.38% |
| 3-mo | -36.92% |
| 6-mo | -16.86% |
| 1-year | 24.89% |
| 3-year | -57.33% |
| 5-year | -62.80% |
| YTD | -4.38% |
| 2023 | -18.63% |
| 2022 | -42.96% |
| 2021 | -40.79% |
| 2020 | 6.68% |
| 2019 | N/A |
Loading social stream, please wait...